Long-term analysis of infections and associated risk factors in patients with multiple sclerosis treated with ocrelizumab: pooled analysis of 13 interventional clinical trialsTobias Derfuß, Amit Bar‐Or, Licínio Craveiro et al.|Therapeutic Advances in Neurological Disorders|2024Cited by 23